Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)
Clinical trial NCT03909724 · UNKNOWN
Trial details
- NCT number
- NCT03909724
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.